Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in ...

Moderna's Spikevax vaccine has been fully approved for children with high-risk conditions, the first vaccine to do so.

Moderna, Inc. (MRNA) on Thursday announced that the U.S. Food and Drug Administration (FDA) has fully approved its COVID-19 ...

The full approval of Spikevax covers children aged six months through 11 years who are at increased risk for severe COVID-19, transitioning the vaccine from emergency use to full licensure.

Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease ...

FDA-approved Spikevax has the same formulation as the Moderna COVID-19 vaccine that was previously authorized for emergency use in the U.S.

Spikevax has the same formulation as the Moderna COVID-19 vaccine that was authorized for emergency use (EUA) by the U.S. Food and Drug Administration (FDA) on Dec. 18, 2020, according to the FDA ...

FDA-approved Spikevax has the same formulation as the Moderna COVID-19 vaccine that was previously authorized for emergency use in the U.S.

Spikevax has the same formulation as the Moderna COVID-19 vaccine that was authorized for emergency use (EUA) by the U.S. Food and Drug Administration (FDA) on Dec. 18, 2020, according to the FDA ...

FDA-approved Spikevax has the same formulation as the Moderna COVID-19 vaccine that was previously authorized for emergency use in the U.S.

Spikevax has the same formulation as the Moderna COVID-19 vaccine that was authorized for emergency use (EUA) by the U.S. Food and Drug Administration (FDA) on Dec. 18, 2020, according to the FDA ...

FDA-approved Spikevax has the same formulation as the Moderna COVID-19 vaccine that was previously authorized for emergency use in the U.S.